--- title: About — Lyvup description: Lyvup is an Amsterdam-based digital health company developing blended-care platforms for chronic disease — in collaboration with Amsterdam UMC, TU Delft, TU Eindhoven, and UvA. --- Lyvup. - [Home](https://lyvup.com/?hsLang=en) - About - [Solutions](https://lyvup.com/solutions?hsLang=en) - [Services](https://lyvup.com/services?hsLang=en) - [Research](https://lyvup.com/research?hsLang=en) - [Platform](https://lyvup.com/platform?hsLang=en) - [Contact](https://lyvup.com/contact?hsLang=en) Discuss a Pilot [Home](https://lyvup.com/?hsLang=en) [About](https://lyvup.com/about?hsLang=en) [Solutions](https://lyvup.com/solutions?hsLang=en) [Services](https://lyvup.com/services?hsLang=en) [Research](https://lyvup.com/research?hsLang=en) [Platform](https://lyvup.com/platform?hsLang=en) [Contact](https://lyvup.com/contact?hsLang=en) [Discuss a Pilot](https://lyvup.com/contact?hsLang=en) About # A digital health company at the intersection of AI, behavioral science, medical technology, and clinical research. We develop platforms that make chronic care more responsive, more personalised, and more grounded in evidence — in close collaboration with academic medical centres, universities, and clinical partners. ## Chronic care has long been designed around populations. We are building the tools to make it work for individuals. Standard protocols deliver standard outcomes. For many patients with chronic conditions, that is not sufficient. Variation in biology, lifestyle, environment, and motivation means that what works for the population average may not work — or may actively fail — for a given individual. Lyvup was founded on the conviction that the technology to address this exists, but has not yet been integrated into care in a clinically rigorous, scalable way. Our work is to build that integration — through platforms that measure continuously, reason individually, and guide persistently. We do this in sustained collaboration with leading research institutions and clinical partners, because the scientific rigour has to match the technical ambition. ## Our work is built on collaboration. Lyvup's platforms are developed in close partnership with academic medical centres, universities, and clinical research institutions — including the University of Amsterdam, Amsterdam UMC, TU Delft, and TU Eindhoven. Scientific validation is not a final step — it is part of the development process from the outset. UvA Universiteit van Amsterdam Amsterdam UMC Academic Medical Centre TU Delft Delft University of Technology TU/e Eindhoven University of Technology ★ ★ ★ ★ ★ ★ Horizon Europe EU Research Programme ## What guides our work. These are not mission statement abstractions. They reflect the decisions we make in how we build, who we collaborate with, and what we are willing to ship. 01 ### Continuous over episodic A periodic consultation offers a snapshot. Chronic conditions evolve continuously, and so should the care that addresses them. We build systems designed for the interval between appointments, not just for the appointment itself. 02 ### Individual over average Population-level protocols are a starting point, not a destination. Every platform we develop is built around the assumption that individual variation matters — in biology, in behavior, in context — and that care should reflect that variation. 03 ### Evidence before scale We do not ship interventions that have not been validated. Our development process is embedded in clinical research from the outset — with academic partners, peer-reviewed methodology, and measurable outcomes as the standard, not the aspiration. 04 ### Infrastructure over application We are not building apps. We are building the underlying layer — where biosensors, AI, and digital therapeutics are integrated into a coherent platform that serves patients, clinicians, pharmaceutical partners, and payers simultaneously. Lyvup is led by its founders and operates in close collaboration with a Scientific Advisory Board that includes active clinicians and researchers from our partner institutions. ## The European standard for continuous, personalised chronic care — by 2031. "Lyvup's ambition is to be the backbone on which Europe's next generation of chronic care and lifestyle medicine runs — the platform where sensors, AI and digital therapeutics converge into a single layer that works for patients, clinicians, pharma, and payers." We are building toward a future in which every person with a chronic condition has access to care that is genuinely adapted to them — starting in metabolic and cardiovascular health, and extending into mental health and lifestyle medicine. ## Health data deserves the highest standard of protection. We build accordingly. The data processed through Lyvup's platforms — from connected wearables, smart devices, and Lyvup's own sensors — includes health information — classified under the GDPR as special category data, requiring a correspondingly higher level of protection. This shapes every architectural and operational decision we make. Data stays in Europe — by design, not by default. All data processed through Lyvup's platforms is stored exclusively on European servers. This is a hard architectural constraint, not a policy choice that can be overridden. For pharmaceutical and clinical partners operating under EU law, this means no ambiguity about jurisdiction, applicable regulation, or cross-border transfer obligations. European servers only GDPR-compliant processing of special category health data. Lyvup processes personal health data in accordance with the General Data Protection Regulation (GDPR / AVG). Health data is handled as special category data under Article 9 GDPR, with explicit consent frameworks, defined processing purposes, and documented retention policies. Data Processing Agreements (DPAs) are provided as standard for all B2B partners. GDPR / AVG Working toward ISO 27001 and NEN 7510 certification. We are actively building our information security management system toward ISO 27001 certification — the international standard for information security — and NEN 7510, the Dutch healthcare-specific information security norm. These are not aspirational targets; they are active implementation programmes integrated into our operational development. ISO 27001 — in progress NEN 7510 — in progress Medical Device Regulation on the roadmap for clinical products. As Lyvup's clinical platforms advance toward regulated medical device classification, we are building toward compliance with the EU Medical Device Regulation (MDR). Our development process — co-conducted with clinical partners including Amsterdam UMC — is structured to meet the evidentiary and quality management requirements that MDR certification demands. MDR — roadmap ## Interested in collaborating or learning more about our research? Explore Research Collaboration → Lyvup. Extending chronic care beyond the consultation room — combining biosensor data, AI-driven intelligence, and behavioural science to strengthen what healthcare professionals and patients achieve together. #### Navigate - [Home](https://lyvup.com/?hsLang=en) - [About](https://lyvup.com/about?hsLang=en) - [Solutions](https://lyvup.com/solutions?hsLang=en) - [Services](https://lyvup.com/services?hsLang=en) - [Research](https://lyvup.com/research?hsLang=en) - [Platform](https://lyvup.com/platform?hsLang=en) - [Contact](https://lyvup.com/contact?hsLang=en) #### Research - [Publications](https://lyvup.com/research?hsLang=en) - [For Patients](https://lyvup.com/patients?hsLang=en) #### Company - [Careers](https://lyvup.com/careers?hsLang=en) - [Investors](https://lyvup.com/investors?hsLang=en) - [Contact](https://lyvup.com/contact?hsLang=en) © 2026 Lyvup B.V. — AmsterdamKvK: 80366708 We use cookies Lyvup uses cookies to ensure the website functions correctly (necessary) and, with your consent, to understand how visitors use our site (analytics). We do not use advertising cookies. For more information, see our [Privacy Policy](https://lyvup.com/privacy?hsLang=en) and [Cookie Policy](https://lyvup.com/cookie-policy?hsLang=en). Accept all Necessary only Manage preferences → Cookie preferences Select which cookies you are willing to accept. You can change your preferences at any time by clicking "Cookie settings" in the footer. Necessary cookies Required for the website to function. These cannot be disabled. They include session management and security cookies. No personal data is shared with third parties. Analytics cookies Help us understand how visitors interact with the website — which pages are visited, how long visitors stay, and where they come from. This data is aggregated and anonymised. We use HubSpot Analytics. Marketing cookies Used to track visitors across websites for the purpose of displaying relevant content. We do not currently use marketing cookies, but this setting applies to any future integrations (e.g. LinkedIn Insight Tag). Cancel Save preferences